Vimarsana
Biggest News Aggregation in the World

Page 4 - Greg Mayes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greg Mayes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greg Mayes Today - Breaking & Trending Today

Reunion Neuroscience Inc. Appoints Greg Mayes as President - Vimarsana News

Reunion Neuroscience Inc. Appoints Greg Mayes as President

Bringing a 20-Year Track Record of Success in the Biopharma Industry, Mayes Succeeds Joseph del Moral, Who Assumes the Role of Chairman...

Reunion Neuroscience Names Greg Mayes As President And CEO - Vimarsana News

Reunion Neuroscience Names Greg Mayes As President And CEO

(RTTNews) - Reunion Neuroscience Inc. (REUN, REUN.TO) announced Wednesday the appointment of Greg Mayes as President and Chief Executive Officer. ...

Antios Therapeutics Announces Notice of Allowance for U.S. Patent on Phosphoramidates for the Treatment of Hepatitis B Virus - Vimarsana News

Antios Therapeutics Announces Notice of Allowance for U.S. Patent on Phosphoramidates for the Treatment of Hepatitis B Virus

/PRNewswire/ -- Antios Therapeutics, Inc. (Antios), a clinical-stage biopharmaceutical company developing innovative therapies to treat and cure chronic...

Antios Therapeutics Announces Notice of Allowance for U.S. Patent on Phosphoramidates for the Treatment of Hepatitis B Virus - Vimarsana News

Antios Therapeutics Announces Notice of Allowance for U.S. Patent on Phosphoramidates for the Treatment of Hepatitis B Virus

/PRNewswire/ -- Antios Therapeutics, Inc. (Antios), a clinical-stage biopharmaceutical company developing innovative therapies to treat and cure chronic...

Antios Therapeutics Raises $75 Million in a Series B-1 Funding to Advance Clinical Programs for HBV - Vimarsana News

Antios Therapeutics Raises $75 Million in a Series B-1 Funding to Advance Clinical Programs for HBV

/PRNewswire/ -- Antios Therapeutics, Inc. ("Antios"), a clinical-stage biopharmaceutical company developing innovative therapies to treat and cure chronic...